孟曼, 毕金玲, 黄勇. 脑转移瘤全脑放疗疗效与预后相关因素分析[J]. 中国辐射卫生, 2019, 28(4): 458-461,472.
MENG Man, BI Jinling, HUANG Yong. Analysis of factors related to the efficacy and prognosis of brain metastases in whole brain radiotherapy. , 2019, 28(4): 458-461,472.
[1] Berghoff A S, Schur S, Fureder L M, et al.Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers[J].ESMO Open,2016,1(2):e000024. [2] Sperduto P W, Kased N, Roberge D, et al.Summary report on the graded prognostic assessment:an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases[J].JCO,2012,30(4):419-425. [3] Jeene P M, de Vries K C, van Nes J G H, et al. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014[J].Acta Oncologica,2018,57(5):637-643. [4] Brown P D, Ahluwalia M S, Khan O H, et al. Whole-brain radiotherapy for brain metastases:evolution or revolution?[J].JCO,2018,36(5):483-491. [5] Greene-Schloesser D, Moore E, Robbins M E. Molecular pathways:radiation-induced cognitive impairment[J].Clinical Cancer Research,2013,19(9):2294-2300. [6] 张菲菲,程怀东,王年飞,等.不同部位脑转移瘤全脑放疗后近期认知功能改变的研究[J].安徽医学,2014,35(6):717-720. [7] Mulvenna P, Nankivell M, Barton R, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ):results from a phase 3, non-inferiority, randomised trial[J].The Lancet,2016,388(10055):2004-2014. [8] 汪步海,李颖,刘丽琴,等.应用海马保护技术预防全脑放疗患者认知功能障碍研究[J].中华肿瘤防治杂志,2015,22(18):1470-1474. [9] 景莉,刘天星,王雅静.不同分割剂量全脑放射治疗脑转移瘤疗效分析[J].人民军医,2015,58(5):534-535. [10] 胡宗涛,费振乐,彭勇,等.伽玛刀联合全脑放疗治疗脑转移瘤近期疗效观察[J].安徽医学,2010,31(10):1157-1158. [11] 徐磊,周伟,刘科.GFP标记Lewis肺癌细胞3LL颈内动脉注射建立脑转移瘤动物模型的可行性研究[J].重庆医学,2013,42(23):2754-2757. [12] 赵铭,兰胜民,张承刚,等.脑转移瘤全脑放疗中血脑屏障通透性的研[J]. 肿瘤学杂志,2005,11(4):268. [13] 郭宇玲,李丽芳,徐丽瑶,等.全脑放疗联合伊立替康治疗非小细胞肺癌脑转移的Ⅰ期临床试验研究[J].中国全科医学,2014,17(21):2445-2447,2456. [14] 汤志谋,许海富,万会平.多西紫杉醇和顺铂联合全脑放疗治疗非小细胞肺癌脑转移的疗效[J].实用癌症杂志,2011,26(5):486-489. [15] 白若伦.全脑放疗同步替尼泊甙加顺铂化疗治疗肺癌脑转移临床分析[J]. 河北医药,2010,32(20):2879-2880. [16] 张明,冉俊涛,王小虎,等.全脑放疗联合替莫唑胺治疗肺癌脑转移疗效观察[J].现代肿瘤医学,2016,24(3):371-374.[17] 岳顺,张大红,袁颖.全脑放疗联合靶向治疗与同步放、化疗治疗非小细胞肺癌脑转移的临床疗效[J].安徽医药,2017,21(1):123-126.[18] 王海霞,单国用,刘兴安,等.伽马刀治疗多发脑转移瘤预后的影响因素分析[J].现代肿瘤医学,2017,25(12):1891-1894.[19] 宋云风,单国用,高松涛.全脑放疗后联合伽马刀补量治疗脑多发转移瘤的临床研究[J].中国社区医师,2016,32(21):24-25.[20] Zhou L, Liu J, Xue J X, et al. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer[J]. Radiat Oncol, 2014, 9(1):117.[21] 张扬帆,毕金玲,黄勇.平均床值法摆位技术在颈椎骨转移瘤调强放疗中的应用研究[J].中国辐射卫生,2018,27(4):339-341[22] 宋俊韬,李学源,聂东.两种适形放疗技术在肺癌脑转移瘤中的疗效对比[J].中国辐射卫生,2016,25(1):104-106.